Safety and efficacy of transcatheter embolization for pulmonary arteriovenous fistula: a 21-year retrospective study
Frontiers in Cardiovascular Medicine · 29.05.2026 · 13
DOI: 10.3389/fcvm.2026.1732994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 29.05.2026. Verfasst von Hong Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, China. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to evaluate the safety and efficacy of transcatheter embolization (TCE) for pulmonary arteriovenous fistula (PAVF).
Methods
From January 1, 2003 to December 31, 2024, 28 patients (13 male, 15 female) with 41 PAVFs underwent TCE. Changes in arterial oxygen saturation (SaO 2 ), procedural success rate, reperfusion rate, and complications were evaluated.
Results
The procedural success rate was 100%, with an immediate complete occlusion rate of 87.8%.Postoperative SaO2 was significantly higher than that before operation (92.0% vs. 84.1%, P < 0.001). The 41 PAVFs were divided into four groups (coil group [ n = 6], MemoPart PDA occluder group [ n = 22], ADO II group [ n = 7], and AVP I group [ n = 6]). The average diameter of the arteries was 3.17 ± 0.7 mm, 11.86 ± 3.31 mm, 5.98 ± 2.54 mm, and 8.72 ± 3.78 mm, respectively, showing a statistically significant difference between groups ( P < 0.001). The average clinical follow-up time was 19.46 ± 26.04 months (range: 6–162 months). During the follow-up period, 2 patients (7.14%) developed fever and 1 patient (3.57%) developed pleural effusion. 1 case (14.29%) of PAVFs experienced reperfusion in the ADO II group, while reperfusion did not occur in the other three groups, and the difference was not statistically significant ( P = 0.463).
Conclusion
The adaptable utilization of various occluders can enhance the success rate of achieving effective occlusion. TCE for PAVFs demonstrates high safety and efficacy, with excellent procedural success rates and sustained long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, China.
Zitieren
APA
Lu, H., Wang, J., Xiao, J., Wang, Z., Yao, H., Li, B., Mi, Y., & Wang, Q. (2026). Safety and efficacy of transcatheter embolization for pulmonary arteriovenous fistula: a 21-year retrospective study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1732994
Vancouver
Lu H, Wang J, Xiao J, Wang Z, Yao H, Li B, et al. Safety and efficacy of transcatheter embolization for pulmonary arteriovenous fistula: a 21-year retrospective study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1732994
BibTeX
@article{Lu2026,
author = {Lu, Hong and Wang, Jianming and Xiao, Jiawang and Wang, Zhongchao and Yao, Hui and Li, Benshen and Mi, Yuan and Wang, Qiguang},
title = {Safety and efficacy of transcatheter embolization for pulmonary arteriovenous fistula: a 21-year retrospective study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1732994}
}
EUVIMED